Launch disruption on global pharmaceutical market due to coronavirus 2020-2025

Published by
Matej Mikulic,
Nov 27, 2020
It is estimated that the disruption in launches of new pharmaceutical products due to COVID-19 will have an aggregated negative impact of around 19 billion U.S. dollars until 2025. The first significant recovery is expected from 2026 on.

Impact of launch disruptions on the global pharmaceutical market due to COVID-19 from 2020 to 2025* (in billion U.S. dollars)

Loading statistic...

© Statista 2023
You need to log in to download this statistic
Register for free
Already a member?
Log in
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

2020

Region

Worldwide

Survey time period

as of April 2020

Supplementary notes

* All values are projected and rounded.

Citation formats
Statista Accounts: Access All Statistics. Starting from $468 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$69 USD $39 USD / Month *
in the first 12 months
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Coronavirus: the pharma and medtech response "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Statistics on Coronavirus: the pharma and medtech response

Pharma - before the pandemic

6

Treatments and vaccines

8

Focus: BioNTech and Moderna

7

Opinions on COVID-19 vaccines

6

Business impact

4

Medtech - before the pandemic

5

Ventilators and testing

7

Further related statistics

19

Further Content: You might find this interesting as well

Statistics

Topics

Coronavirus (COVID-19) in JapanPharmaceutical industry in JapanTravel and tourism industry in JapanHealth care in JapanHospitals in Japan
Statista Accounts: Access All Statistics. Starting from $468 USD / Year
Learn more about how Statista can support your business.
Menu